Effectiveness of Electric Stimulation Therapy in Raynaud's Phenomenon

Status Completed

Clinical Trial Summary

The purpose of this study is to analyze the effects of an intervention with galvanic electrical current on the number of attacks , temperature, pain, peripheral blow flow and upper limb functionality in patients with Raynaud's Phenomenon in comparison to a control group that will maintain their habitual treatment.

Clinical Trial Description

Raynaud's Phenomenon is a disorder that causes pain and functional limitation in people who suffer it. Investigators considerer that the application of an electrotherapy intervention with galvanic current, thanks to its vasodilator action, will produce clinically significant improvements in the number of attacks, temperature and blood flow of patients with Raynaud's Phenomenon, which can lead to a decrease in pain associated, frequency and severity of ischemic attacks and therefore an improvement in the functionality of the upper limbs. The experimental group will receive an electrotherapy treatment using galvanic current. To apply the treatment, we will place the patient seated, with their hands inside two containers filled with water up to the limit of their nails without touching them. Next we will connect the electrodes and apply a galvanic current for 10 minutes, there will be a minute of rest for the patient while we change the polarity of this current and we will apply it another 10 minutes. The intensity of the current depends on the threshold of the patient. The control group will maintain their usual conservative and pharmacological treatment without receiving electrotherapy ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03699436
Study type	Interventional
Source	Universidad de Granada
Contact
Status	Completed
Phase	N/A
Start date	October 1, 2018
Completion date	February 20, 2019

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT03393325` - Tadalafil-Delivra and Raynaud's Phenomenon
Recruiting	`NCT03749577` - Nutritional Strategies to Increase Nitric Oxide Signaling in Raynaud's Phenomenon	N/A
Enrolling by invitation	`NCT06291142` - Early Diagnosis of SSc in the General Rheumatology Clinic - Pilot
Recruiting	`NCT03984422` - Application for Monitoring and Evaluation of Raynaud's Phenomenon
Recruiting	`NCT04015193` - Follow-up of SPTS in Patients With Raynaud's Phenomenon
Not yet recruiting	`NCT03972566` - Localized Effects of PBM and Exogenous NO on CREST Patients Calcinosis Cutis & Raynaud Phenomenon
Completed	`NCT04854850` - Apollo Device for Fatigue in Systemic Sclerosis	N/A
Completed	`NCT03129178` - Beet the Cold: The Effect of Inorganic Nitrate Supplementation in Individuals With Raynaud's Phenomenon	N/A
Completed	`NCT04388176` - Cold Challenge With C21 in RP	Phase 2
Completed	`NCT01280266` - Efficacy Study of PDE-5 Inhibitor and Calcium Channel Inhibitor for the Treatment of Secondary Raynaud Phenomenon	Phase 2/Phase 3
Completed	`NCT04644523` - Dermoscopy in Primary Raynaud's Phenomenon
Completed	`NCT03094910` - Investigation of the Rewarming og the Fingers After Cooling and the Autonomic Nervous System in Raynaud's Phenomenon	N/A
Recruiting	`NCT05204784` - Rheopheresis for Raynaud's and Digital Ulcers in Systemic Sclerosis	N/A
Recruiting	`NCT05125029` - Botulinum Toxin in Raynaud's Phenomenon	Phase 4
Terminated	`NCT03639766` - The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud's Phenomenon	Phase 4
Withdrawn	`NCT04898036` - Phototherapy For Treatment Of Raynaud's Phenomenon	N/A
Terminated	`NCT03869008` - Potential Benefit for Non Invasive Vagus Nerve Stimulation Using GammaCore in the Treatment of Raynaud's Phenomena.	N/A
Recruiting	`NCT01347008` - Effect of Sildenafil on the Microcirculatory Blood Flow and Endothelial Progenitor Cells in Systemic Sclerosis	Phase 3